Your browser doesn't support javascript.
loading
Utilizing chemokines in cancer immunotherapy.
Märkl, Florian; Huynh, Duc; Endres, Stefan; Kobold, Sebastian.
Afiliação
  • Märkl F; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Huynh D; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany.
  • Endres S; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Research Center for Environmental Health (HMGU), Neu
  • Kobold S; Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, Research Center for Environmental Health (HMGU), Neu
Trends Cancer ; 8(8): 670-682, 2022 08.
Article em En | MEDLINE | ID: mdl-35501268

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha